Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 181 clinical trials
Transplantation Using Reduced Intensity Approach for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow

-matched related donors. Preparation before transplant includes the chemotherapy drugs hydroxyurea, fludarabine, thiotepa, anti-thymocyte globulin, and cyclophosphamide. It also includes radiation.

blood transfusion
fludarabine
hemoglobin s
bone marrow transplant
anti-thymocyte globulin
  • 33 views
  • 13 Feb, 2021
  • 1 location
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

to give higher doses of chemotherapy drugs and kill more tumor cells.

tumor cells
metastasis
estrogen
immunohistochemistry
breast cancer
  • 76 views
  • 24 Jan, 2021
  • 1 location
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

The purpose of this study is to find out whether giving the study drug pembrolizumab in combination with the chemotherapy drugs melphalan and dactinomycin, delivered directly to the affected arm

alveolar soft part sarcoma
advanced sarcoma
platelet count
undifferentiated pleomorphic sarcoma
metastasis
  • 0 views
  • 05 Feb, 2021
  • 7 locations
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

The purpose of this study is to compare any good and bad effects the study drug atezolizumab has on the cancer when combined with the standard chemotherapy drugs gemcitabine and cisplatin (or GC

metastasis
platelet count
chemotherapy drug
gilbert's syndrome
bladder cancer
  • 44 views
  • 24 May, 2021
  • 16 locations
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance

resistance may work better than discontinuing ibrutinib and switching to other chemotherapy drugs.

chemotherapy drugs
lymphoid leukemia
ibrutinib
beta human chorionic gonadotrophin
neutrophil count
  • 0 views
  • 25 Jan, 2021
  • 3 locations
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy

condition caused by exposure to chemotherapy drugs that may involve numbness/tingling and/or pain in the hands and feet, which can have adverse effects on daily life. Whole body vibration may cause weight

paresthesia
neuropathy
primary cancer
peripheral neuropathy
cancer
  • 11 views
  • 25 Jan, 2021
  • 2 locations
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

combination of 3 chemotherapy drugs, cyclophosphamide, doxorubicin, and vincristine. These 3 chemotherapy drugs, as well as oral azacitidine, work in different ways to stop the growth of cancer cells, either

monoclonal antibodies
monoclonal protein
direct bilirubin
diffuse large b-cell lymphoma
vincristine
  • 0 views
  • 16 Jun, 2021
  • 11 locations
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma

(refractory). Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, either by killing the cells, by

oxaliplatin
hiv disease
antiretroviral agents
etoposide
platelet count
  • 17 views
  • 22 Mar, 2021
  • 7 locations
Abatacept Ixazomib Citrate and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy

proteins that are present on multiple myeloma cells that have been shown to protect against chemotherapy. Drugs used in chemotherapy, such as ixazomib citrate and dexamethasone, work in different ways to

tumor cells
carfilzomib
platelet count
neutrophil count
cancer
  • 4 views
  • 11 Jun, 2021
  • 3 locations
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

This randomized phase II trial includes a blood stem cell transplant from an unrelated donor to treat blood cancer. The treatment also includes chemotherapy drugs, but in lower doses than

hodgkin's disease
waldenstrom's macroglobulinemia
17p deletion
stem cell transplantation
hla-a
  • 64 views
  • 11 Apr, 2021
  • 1 location